DNTH
Dianthus Therapeutics Inc.
96.80$
-4.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | 136.9% | 2.3% | 12.6% | 6.6% | – | |
| – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | 854.1% | 457.8% | 1,162.1% | 1,332.9% | 7,153.1% | |
| – | – | – | – | – | 132.5% | 105.1% | 642.6% | 400.9% | 1,686.2% | |
| – | – | – | – | – | 986.6% | 562.9% | 1,804.7% | 1,733.7% | 8,839.3% | |
| – | – | – | – | – | -886.6% | -462.9% | -1,704.7% | -1,633.7% | -8,739.3% | |
| – | – | – | – | – | 240.9% | – | – | – | – | |
| – | – | – | – | – | -888.1% | -443.8% | -1,541.2% | -1,362.8% | -7,973.3% | |
| – | – | – | – | – | -135.3% | -20.0% | 6.6% | – | – | |
| – | – | – | – | – | -888.1% | -443.8% | -1,541.2% | -1,362.8% | -7,973.3% | |
| – | – | – | – | – | -751.3% | -441.5% | -1,528.7% | -1,356.2% | -7,952.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.